SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5anb'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AKD_A_CAMA420_0 (CYTOCHROME P450CAM)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 11	PHE K 873 LEU K 887 VAL K 890 GLY K 889 THR K 763	None	1.17A	1akdA-5anbK: undetectable	1akdA-5anbK: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BDW_B_DVAB8_0 (GRAMICIDIN A)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	VAL K 232 VAL K 144 TRP K 268	None	0.93A	1bdwA-5anbK: undetectable 1bdwB-5anbK: undetectable	1bdwA-5anbK: 1.54 1bdwB-5anbK: 1.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ8_B_CAMB502_0 (CYTOCHROME P450-CAM)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 9	PHE K 873 LEU K 887 VAL K 890 GLY K 889 THR K 763	None	1.38A	1dz8B-5anbK: undetectable	1dz8B-5anbK: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ9_B_CAMB502_0 (CYTOCHROME P450-CAM)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 9	PHE K 873 LEU K 887 VAL K 890 GLY K 889 THR K 763	None	1.39A	1dz9B-5anbK: undetectable	1dz9B-5anbK: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FBM_B_RTLB951_1 (PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN))	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 4	THR K 992 LEU K 996 VAL K 999 LEU K1003	None	1.08A	1fbmB-5anbK: undetectable	1fbmB-5anbK: 4.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LIN_A_TFPA155_1 (CALMODULIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 7	GLN K 393 GLU K 391 MET K 400 ALA K 398	None	1.29A	1linA-5anbK: undetectable	1linA-5anbK: 8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MJQ_B_SAMB200_0 (METHIONINE REPRESSOR)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 11	GLU K 904 GLY K 924 LEU K 865 LEU K 748 PRO K 745	None	1.46A	1mjqA-5anbK: undetectable 1mjqB-5anbK: undetectable	1mjqA-5anbK: 8.47 1mjqB-5anbK: 8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MJQ_B_SAMB200_0 (METHIONINE REPRESSOR)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 11	GLU K 926 GLY K 924 LEU K 865 LEU K 748 PRO K 745	None	1.29A	1mjqA-5anbK: undetectable 1mjqB-5anbK: undetectable	1mjqA-5anbK: 8.47 1mjqB-5anbK: 8.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1OE2_A_CUA502_0 (DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	GLU K 102 HIS K 96 HIS K 666	None	0.66A	1oe2A-5anbK: undetectable	1oe2A-5anbK: 14.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_A_BEZA501_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	4 / 7	ARG F 32 ALA F 29 ILE F 65 PRO F 93	U N1222 ( 3.3A) None None None	0.91A	1oniA-5anbF: undetectable 1oniB-5anbF: undetectable	1oniA-5anbF: 20.91 1oniB-5anbF: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_I_BEZI517_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	4 / 7	ILE F 65 PRO F 93 ARG F 32 ALA F 29	None None U N1222 ( 3.3A) None	0.92A	1oniG-5anbF: undetectable 1oniI-5anbF: undetectable	1oniG-5anbF: 20.91 1oniI-5anbF: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_B_ACTB861_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	GLY K 95 GLN K 126 VAL K 130 SER K 100	None	1.38A	1p6kB-5anbK: undetectable	1p6kB-5anbK: 16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PBC_A_BHAA396_0 (P-HYDROXYBENZOATE HYDROXYLASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 10	GLY K1035 VAL K 665 LEU K1052 TYR K 985 LEU K1028	None	1.35A	1pbcA-5anbK: undetectable	1pbcA-5anbK: 16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RS6_B_ACTB861_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	GLY K 95 GLN K 126 VAL K 130 SER K 100	None	1.39A	1rs6B-5anbK: undetectable	1rs6B-5anbK: 16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T46_A_STIA3_2 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	4 / 7	VAL F 129 VAL F 89 CYH F 12 ARG F 10	None None None G N3189 ( 3.9A)	1.15A	1t46A-5anbF: undetectable	1t46A-5anbF: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZLQ_A_ACTA1507_0 (NICKEL-BINDING PERIPLASMIC PROTEIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	GLN K 797 HIS K 793 ARG K 817	None	1.07A	1zlqA-5anbK: undetectable	1zlqA-5anbK: 18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZQ_B_ACTB861_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	GLY K 95 GLN K 126 VAL K 130 SER K 100	None	1.41A	1zzqB-5anbK: undetectable	1zzqB-5anbK: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_ACTB861_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	GLY K 95 GLN K 126 VAL K 130 SER K 100	None	1.40A	1zzuB-5anbK: undetectable	1zzuB-5anbK: 16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A1N_A_CAMA1422_0 (CYTOCHROME P450-CAM)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 11	PHE K 873 LEU K 887 VAL K 890 GLY K 889 THR K 763	None	1.19A	2a1nA-5anbK: undetectable	2a1nA-5anbK: 16.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2A3A_A_TEPA1436_1 (CHITINASE)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	3 / 3	ASP F 83 PHE F 46 ARG F 38	None	0.64A	2a3aA-5anbF: undetectable	2a3aA-5anbF: 19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B9E_A_SAMA1201_0 (NOL1/NOP2/SUN DOMAIN FAMILY, MEMBER 5 ISOFORM 2)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	GLY K 112 ASN K 21 LEU K 136 ARG K 373 PHE K 612	None	1.44A	2b9eA-5anbK: 2.5	2b9eA-5anbK: 14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OAX_D_SNLD4001_2 (MINERALOCORTICOID RECEPTOR)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	4 / 5	LEU I 104 LEU I 70 CYH I 76 THR I 75	None	1.17A	2oaxD-5anbI: undetectable	2oaxD-5anbI: 24.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_B_CHDB928_0 (FERROCHELATASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	PHE K 678 ARG K 60 HIS K 666 LEU K 667 VAL K 620	None	1.27A	2qd4B-5anbK: 2.6	2qd4B-5anbK: 16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RHM_B_BEZB194_0 (PUTATIVE KINASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	PRO K 579 ILE K 19 ARG K 510 ASP K 111	None	1.41A	2rhmB-5anbK: undetectable	2rhmB-5anbK: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RHM_D_BEZD194_0 (PUTATIVE KINASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	PRO K 579 ILE K 19 ARG K 510 ASP K 111	None	1.38A	2rhmD-5anbK: 2.0	2rhmD-5anbK: 10.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDB_A_NPSA1591_1 (SERUM ALBUMIN)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	4 / 8	PHE F 159 PHE F 136 ARG F 154 GLY F 68	None None A N3171 ( 3.0A) None	0.93A	2vdbA-5anbF: undetectable	2vdbA-5anbF: 15.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XCT_H_CPFH1020_1 (DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	ARG K 619 GLU K 653 SER K 101	None	0.86A	2xctD-5anbK: 2.8	2xctD-5anbK: 21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XDC_D_DVAD8_0 (GRAMICIDIN A)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	TRP K 848 VAL K 820 TRP K 801	None	1.34A	2xdcC-5anbK: undetectable 2xdcD-5anbK: undetectable	2xdcC-5anbK: 1.54 2xdcD-5anbK: 1.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YA7_C_ZMRC1776_2 (NEURAMINIDASE A)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 6	ARG K 373 ASP K 111 ILE K 19 GLN K 13	None	1.38A	2ya7C-5anbK: undetectable	2ya7C-5anbK: 18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A65_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 12	ALA I 64 VAL I 135 ASN I 66 GLY I 105 ILE I 108	None	1.43A	3a65A-5anbI: undetectable	3a65A-5anbI: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_F_SVRF502_3 (PHOSPHOLIPASE A2)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	VAL K 582 LEU K 583 GLY K 584 ILE K 585 PHE K 413	None	1.26A	3bjwF-5anbK: undetectable	3bjwF-5anbK: 7.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DL9_A_V2HA602_0 (CYTOCHROME P450 2R1)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 12	THR I 210 VAL I 199 ALA I 204 ILE I 221 THR I 155	None	1.24A	3dl9A-5anbI: undetectable	3dl9A-5anbI: 17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DL9_B_V2HB602_0 (CYTOCHROME P450 2R1)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 12	THR I 210 VAL I 199 ALA I 204 ILE I 221 THR I 155	None	1.26A	3dl9B-5anbI: undetectable	3dl9B-5anbI: 17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EIG_A_MTXA200_2 (DIHYDROFOLATE REDUCTASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	ASP K 58 ILE K 68 VAL K 97 THR K 105	None	1.15A	3eigA-5anbK: undetectable	3eigA-5anbK: 10.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B304_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	THR K 780 SER K 782 SER K 382 ARG K 536	None	1.32A	3hlwB-5anbK: undetectable	3hlwB-5anbK: 13.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJX_H_HCZH800_1 (GLUTAMATE RECEPTOR 2)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	LYS K 493 PRO K 494 SER K 489 LEU K 496	None	1.20A	3ijxH-5anbK: undetectable	3ijxH-5anbK: 13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ILU_H_HFZH800_1 (GLUTAMATE RECEPTOR 2)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	LYS K 493 PRO K 494 SER K 489 LEU K 496	None	1.28A	3iluH-5anbK: undetectable	3iluH-5anbK: 13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXI_A_CAMA423_0 (CYTOCHROME P450)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 10	LEU I 70 LEU I 71 GLY I 65 THR I 110 VAL I 135	None	1.32A	3lxiA-5anbI: undetectable	3lxiA-5anbI: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LXI_B_CAMB423_0 (CYTOCHROME P450)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 11	LEU I 70 LEU I 71 GLY I 65 THR I 110 VAL I 135	None	1.29A	3lxiB-5anbI: undetectable	3lxiB-5anbI: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q5S_A_ACHA1289_0 (MULTIDRUG-EFFLUX TRANSPORTER 1 REGULATOR)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 6	ASN K 342 TYR K 305 GLU K 154 ILE K 238	None	1.03A	3q5sA-5anbK: undetectable	3q5sA-5anbK: 13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QJ7_A_SPMA264_1 (THYMIDYLATE SYNTHASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 8	ALA K 119 LEU K 151 ASP K 149 SER K 236	None	1.01A	3qj7A-5anbK: undetectable 3qj7D-5anbK: undetectable	3qj7A-5anbK: 12.20 3qj7D-5anbK: 12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T7S_B_SAMB300_0 (PUTATIVE METHYLTRANSFERASE)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	5 / 12	ARG F 38 GLY F 194 GLU F 45 ALA F 195 ASN F 196	None C N1226 ( 3.8A) None G N1225 ( 3.8A) U N1257 ( 3.4A)	1.32A	3t7sB-5anbF: undetectable	3t7sB-5anbF: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T7S_D_SAMD300_0 (PUTATIVE METHYLTRANSFERASE)	5anb	60S RIBOSOMAL PROTEIN L10 (Dictyostelium discoideum)	5 / 12	ARG F 38 GLY F 194 GLU F 45 ALA F 195 ASN F 196	None C N1226 ( 3.8A) None G N1225 ( 3.8A) U N1257 ( 3.4A)	1.33A	3t7sD-5anbF: undetectable	3t7sD-5anbF: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZQ8_D_DVAD8_0 (VAL-GRAMICIDIN A)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	TRP K 848 VAL K 820 TRP K 801	None	0.88A	3zq8C-5anbK: undetectable 3zq8D-5anbK: undetectable	3zq8C-5anbK: 1.54 3zq8D-5anbK: 1.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AGA_A_ACTA1131_0 (LYSOZYME C)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	3 / 3	ASN I 156 ASP I 112 ASN I 21	None	0.77A	4agaA-5anbI: undetectable	4agaA-5anbI: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C9K_B_CAMB424_0 (CYTOCHROME P450)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 9	LEU I 70 LEU I 71 GLY I 65 THR I 110 VAL I 135	None	1.35A	4c9kB-5anbI: undetectable	4c9kB-5anbI: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DC3_A_ADNA401_2 (ADENOSINE KINASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 4	LEU K 766 ILE K 792 GLY K 832 PHE K 826	None	1.10A	4dc3A-5anbK: undetectable	4dc3A-5anbK: 16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_B_ACTB701_0 (RNA (33-MER) RNA POLYMERASE 3D-POL)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	HIS K 353 GLY K 244 ILE K 351	None	0.60A	4k50A-5anbK: undetectable	4k50A-5anbK: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_J_ACTJ701_0 (RNA (33-MER) RNA POLYMERASE 3D-POL)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	HIS K 353 GLY K 244 ILE K 351	None	0.63A	4k50I-5anbK: undetectable	4k50I-5anbK: 17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_C_SAMC601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	TYR K 862 GLY K 866 ASP K 864 ILE K 823 SER K 846	None	1.28A	4obwC-5anbK: undetectable	4obwC-5anbK: 13.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R21_B_STRB601_1 (CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 9	VAL I 92 GLY I 65 ALA I 64 ILE I 97 VAL I 94	None	1.09A	4r21B-5anbI: undetectable	4r21B-5anbI: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1Y_B_LOCB502_1 (TUBULIN BETA CHAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	LEU K 131 LEU K 143 THR K 235 VAL K 123 ILE K 145	None	1.13A	4x1yB-5anbK: undetectable	4x1yB-5anbK: 16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X3M_B_ADNB301_1 (RNA 2'-O RIBOSE METHYLTRANSFERASE)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 9	LEU I 81 ILE I 97 SER I 63 LEU I 71 VAL I 94	None	1.26A	4x3mB-5anbI: undetectable	4x3mB-5anbI: 25.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XQE_A_AG2A505_1 (HOMOSPERMIDINE SYNTHASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	ALA K 859 ASN K 845 GLU K 947 SER K 948 THR K 849	None	1.32A	4xqeA-5anbK: 1.4	4xqeA-5anbK: 18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XQE_B_AG2B504_1 (HOMOSPERMIDINE SYNTHASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	ALA K 859 ASN K 845 GLU K 947 SER K 948 THR K 849	None	1.32A	4xqeB-5anbK: 1.8	4xqeB-5anbK: 18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XRG_B_AG2B502_1 (HOMOSPERMIDINE SYNTHASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	ALA K 859 ASN K 845 GLU K 947 SER K 948 THR K 849	None	1.31A	4xrgB-5anbK: 1.2	4xrgB-5anbK: 18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YIA_B_IMNB401_2 (THYROXINE-BINDING GLOBULIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	LEU K 878 ARG K 970 ARG K1095	None	0.85A	4yiaB-5anbK: undetectable	4yiaB-5anbK: 2.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZE2_A_1YNA602_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 5	ALA K1037 HIS K1056 PRO K1029 PHE K1054	None	1.36A	4ze2A-5anbK: undetectable	4ze2A-5anbK: 19.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DB5_A_CYSA503_0 (CYSTEINE DESULFURASE)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Dictyostelium discoideum; Homo sapiens)	4 / 8	ALA I 183 LYS K 493 HIS I 162 THR I 165	None	1.32A	5db5A-5anbI: undetectable 5db5B-5anbI: undetectable	5db5A-5anbI: 19.61 5db5B-5anbI: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DV4_A_NMYA601_2 (CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	GLU K 802 TRP K 801 ASN K 818	None	1.06A	5dv4A-5anbK: undetectable	5dv4A-5anbK: 16.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESG_A_1YNA701_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 4	LEU K 667 TYR K1090 PRO K 616 ILE K 617	None	1.27A	5esgA-5anbK: undetectable	5esgA-5anbK: 19.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5J6H_A_NCAA402_0 (H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, Q10 ALPHA CHAIN)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	PRO K 691 ARG K 693 GLU K 885	None	0.85A	5j6hA-5anbK: undetectable	5j6hA-5anbK: 14.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JKW_A_TESA601_1 (AROMATASE)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 11	ILE I 97 ASP I 131 VAL I 137 VAL I 117 LEU I 133	None	1.32A	5jkwA-5anbI: undetectable	5jkwA-5anbI: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR0_A_478A101_2 (PROTEASE E35D-APV)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 9	LEU K 583 GLY K 586 VAL K 414 ILE K 522 VAL K 511	None	1.05A	5kr0B-5anbK: undetectable	5kr0B-5anbK: 6.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF3_H_BO2H306_1 (PROTEASOME SUBUNIT BETA TYPE-7 PROTEASOME SUBUNIT BETA TYPE-3)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 10	GLU I 219 CYH I 197 ALA I 159 GLY I 158 THR I 155	None	1.12A	5lf3H-5anbI: undetectable 5lf3I-5anbI: undetectable	5lf3H-5anbI: 21.14 5lf3I-5anbI: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_H_6V8H305_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 11	GLU I 219 CYH I 197 ALA I 159 GLY I 158 THR I 155	None	1.07A	5lf7H-5anbI: undetectable 5lf7I-5anbI: undetectable	5lf7H-5anbI: 21.14 5lf7I-5anbI: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LF7_V_6V8V303_0 (PROTEASOME SUBUNIT BETA TYPE-3 PROTEASOME SUBUNIT BETA TYPE-7)	5anb	EUKARYOTIC TRANSLATION INITIATION FACTOR 6 (Dictyostelium discoideum)	5 / 11	GLU I 219 CYH I 197 ALA I 159 GLY I 158 THR I 155	None	1.09A	5lf7V-5anbI: undetectable 5lf7W-5anbI: undetectable	5lf7V-5anbI: 21.14 5lf7W-5anbI: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C06_D_FI8D1404_1 (DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA')	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	ARG K 250 LYS K 260 ARG K 192	None	1.08A	6c06D-5anbK: undetectable	6c06D-5anbK: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_B_EY4B500_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	4 / 6	VAL K 577 PRO K 366 ALA K 516 THR K 407	None	0.93A	6cduB-5anbK: undetectable 6cduC-5anbK: undetectable	6cduB-5anbK: 15.68 6cduC-5anbK: 15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G1P_B_ACTB403_0 (ADP-RIBOSYLHYDROLASE LIKE 2)	5anb	ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	3 / 3	PHE K1065 ARG K1088 GLN K 978	None	0.86A	6g1pB-5anbK: undetectable	6g1pB-5anbK: 17.27

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AKD_A_CAMA420_0","CYTOCHROME P450CAM","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"PHE K 873;LEU K 887;VAL K 890;GLY K 889;THR K 763","None","1.17A","1akdA-5anbK:undetectable","1akdA-5anbK:16.99"],["1BDW_B_DVAB8_0","GRAMICIDIN A","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"VAL K 232;VAL K 144;TRP K 268","None","0.93A","1bdwA-5anbK:undetectable;1bdwB-5anbK:undetectable","1bdwA-5anbK:1.54;1bdwB-5anbK:1.54"],["1DZ8_B_CAMB502_0","CYTOCHROME P450-CAM","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"PHE K 873;LEU K 887;VAL K 890;GLY K 889;THR K 763","None","1.38A","1dz8B-5anbK:undetectable","1dz8B-5anbK:16.99"],["1DZ9_B_CAMB502_0","CYTOCHROME P450-CAM","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"PHE K 873;LEU K 887;VAL K 890;GLY K 889;THR K 763","None","1.39A","1dz9B-5anbK:undetectable","1dz9B-5anbK:16.99"],["1FBM_B_RTLB951_1","PROTEIN (CARTILAGE OLIGOMERIC MATRIX PROTEIN)","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"THR K 992;LEU K 996;VAL K 999;LEU K1003","None","1.08A","1fbmB-5anbK:undetectable","1fbmB-5anbK:4.03"],["1LIN_A_TFPA155_1","CALMODULIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"GLN K 393;GLU K 391;MET K 400;ALA K 398","None","1.29A","1linA-5anbK:undetectable","1linA-5anbK:8.47"],["1MJQ_B_SAMB200_0","METHIONINE REPRESSOR","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"GLU K 904;GLY K 924;LEU K 865;LEU K 748;PRO K 745","None","1.46A","1mjqA-5anbK:undetectable;1mjqB-5anbK:undetectable","1mjqA-5anbK:8.47;1mjqB-5anbK:8.47"],["1MJQ_B_SAMB200_0","METHIONINE REPRESSOR","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"GLU K 926;GLY K 924;LEU K 865;LEU K 748;PRO K 745","None","1.29A","1mjqA-5anbK:undetectable;1mjqB-5anbK:undetectable","1mjqA-5anbK:8.47;1mjqB-5anbK:8.47"],["1OE2_A_CUA502_0","DISSIMILATORY COPPER-CONTAINING NITRITE REDUCTASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"GLU K 102;HIS K  96;HIS K 666","None","0.66A","1oe2A-5anbK:undetectable","1oe2A-5anbK:14.53"],["1ONI_A_BEZA501_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",4,"ARG F  32;ALA F  29;ILE F  65;PRO F  93","  U N1222 ( 3.3A);None;None;None","0.91A","1oniA-5anbF:undetectable;1oniB-5anbF:undetectable","1oniA-5anbF:20.91;1oniB-5anbF:20.91"],["1ONI_I_BEZI517_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",4,"ILE F  65;PRO F  93;ARG F  32;ALA F  29","None;None;  U N1222 ( 3.3A);None","0.92A","1oniG-5anbF:undetectable;1oniI-5anbF:undetectable","1oniG-5anbF:20.91;1oniI-5anbF:20.91"],["1P6K_B_ACTB861_0","NITRIC-OXIDE SYNTHASE, BRAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"GLY K  95;GLN K 126;VAL K 130;SER K 100","None","1.38A","1p6kB-5anbK:undetectable","1p6kB-5anbK:16.16"],["1PBC_A_BHAA396_0","P-HYDROXYBENZOATE HYDROXYLASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"GLY K1035;VAL K 665;LEU K1052;TYR K 985;LEU K1028","None","1.35A","1pbcA-5anbK:undetectable","1pbcA-5anbK:16.85"],["1RS6_B_ACTB861_0","NITRIC-OXIDE SYNTHASE, BRAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"GLY K  95;GLN K 126;VAL K 130;SER K 100","None","1.39A","1rs6B-5anbK:undetectable","1rs6B-5anbK:16.16"],["1T46_A_STIA3_2","HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",4,"VAL F 129;VAL F  89;CYH F  12;ARG F  10","None;None;None;  G N3189 ( 3.9A)","1.15A","1t46A-5anbF:undetectable","1t46A-5anbF:19.05"],["1ZLQ_A_ACTA1507_0","NICKEL-BINDING PERIPLASMIC PROTEIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"GLN K 797;HIS K 793;ARG K 817","None","1.07A","1zlqA-5anbK:undetectable","1zlqA-5anbK:18.56"],["1ZZQ_B_ACTB861_0","NITRIC-OXIDE SYNTHASE, BRAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"GLY K  95;GLN K 126;VAL K 130;SER K 100","None","1.41A","1zzqB-5anbK:undetectable","1zzqB-5anbK:16.74"],["1ZZU_B_ACTB861_0","NITRIC-OXIDE SYNTHASE, BRAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"GLY K  95;GLN K 126;VAL K 130;SER K 100","None","1.40A","1zzuB-5anbK:undetectable","1zzuB-5anbK:16.83"],["2A1N_A_CAMA1422_0","CYTOCHROME P450-CAM","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"PHE K 873;LEU K 887;VAL K 890;GLY K 889;THR K 763","None","1.19A","2a1nA-5anbK:undetectable","2a1nA-5anbK:16.99"],["2A3A_A_TEPA1436_1","CHITINASE","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",3,"ASP F  83;PHE F  46;ARG F  38","None","0.64A","2a3aA-5anbF:undetectable","2a3aA-5anbF:19.68"],["2B9E_A_SAMA1201_0","NOL1\/NOP2\/SUN DOMAIN FAMILY, MEMBER 5 ISOFORM 2","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"GLY K 112;ASN K  21;LEU K 136;ARG K 373;PHE K 612","None","1.44A","2b9eA-5anbK:2.5","2b9eA-5anbK:14.69"],["2OAX_D_SNLD4001_2","MINERALOCORTICOID RECEPTOR","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",4,"LEU I 104;LEU I  70;CYH I  76;THR I  75","None","1.17A","2oaxD-5anbI:undetectable","2oaxD-5anbI:24.20"],["2QD4_B_CHDB928_0","FERROCHELATASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"PHE K 678;ARG K  60;HIS K 666;LEU K 667;VAL K 620","None","1.27A","2qd4B-5anbK:2.6","2qd4B-5anbK:16.07"],["2RHM_B_BEZB194_0","PUTATIVE KINASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"PRO K 579;ILE K  19;ARG K 510;ASP K 111","None","1.41A","2rhmB-5anbK:undetectable","2rhmB-5anbK:10.64"],["2RHM_D_BEZD194_0","PUTATIVE KINASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"PRO K 579;ILE K  19;ARG K 510;ASP K 111","None","1.38A","2rhmD-5anbK:2.0","2rhmD-5anbK:10.64"],["2VDB_A_NPSA1591_1","SERUM ALBUMIN","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",4,"PHE F 159;PHE F 136;ARG F 154;GLY F  68","None;None;  A N3171 ( 3.0A);None","0.93A","2vdbA-5anbF:undetectable","2vdbA-5anbF:15.51"],["2XCT_H_CPFH1020_1","DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"ARG K 619;GLU K 653;SER K 101","None","0.86A","2xctD-5anbK:2.8","2xctD-5anbK:21.18"],["2XDC_D_DVAD8_0","GRAMICIDIN A","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"TRP K 848;VAL K 820;TRP K 801","None","1.34A","2xdcC-5anbK:undetectable;2xdcD-5anbK:undetectable","2xdcC-5anbK:1.54;2xdcD-5anbK:1.54"],["2YA7_C_ZMRC1776_2","NEURAMINIDASE A","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"ARG K 373;ASP K 111;ILE K  19;GLN K  13","None","1.38A","2ya7C-5anbK:undetectable","2ya7C-5anbK:18.45"],["3A65_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"ALA I  64;VAL I 135;ASN I  66;GLY I 105;ILE I 108","None","1.43A","3a65A-5anbI:undetectable","3a65A-5anbI:21.52"],["3BJW_F_SVRF502_3","PHOSPHOLIPASE A2","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"VAL K 582;LEU K 583;GLY K 584;ILE K 585;PHE K 413","None","1.26A","3bjwF-5anbK:undetectable","3bjwF-5anbK:7.82"],["3DL9_A_V2HA602_0","CYTOCHROME P450 2R1","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"THR I 210;VAL I 199;ALA I 204;ILE I 221;THR I 155","None","1.24A","3dl9A-5anbI:undetectable","3dl9A-5anbI:17.09"],["3DL9_B_V2HB602_0","CYTOCHROME P450 2R1","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"THR I 210;VAL I 199;ALA I 204;ILE I 221;THR I 155","None","1.26A","3dl9B-5anbI:undetectable","3dl9B-5anbI:17.09"],["3EIG_A_MTXA200_2","DIHYDROFOLATE REDUCTASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"ASP K  58;ILE K  68;VAL K  97;THR K 105","None","1.15A","3eigA-5anbK:undetectable","3eigA-5anbK:10.26"],["3HLW_B_CE3B304_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"THR K 780;SER K 782;SER K 382;ARG K 536","None","1.32A","3hlwB-5anbK:undetectable","3hlwB-5anbK:13.62"],["3IJX_H_HCZH800_1","GLUTAMATE RECEPTOR 2","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"LYS K 493;PRO K 494;SER K 489;LEU K 496","None","1.20A","3ijxH-5anbK:undetectable","3ijxH-5anbK:13.43"],["3ILU_H_HFZH800_1","GLUTAMATE RECEPTOR 2","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"LYS K 493;PRO K 494;SER K 489;LEU K 496","None","1.28A","3iluH-5anbK:undetectable","3iluH-5anbK:13.43"],["3LXI_A_CAMA423_0","CYTOCHROME P450","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"LEU I  70;LEU I  71;GLY I  65;THR I 110;VAL I 135","None","1.32A","3lxiA-5anbI:undetectable","3lxiA-5anbI:20.71"],["3LXI_B_CAMB423_0","CYTOCHROME P450","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"LEU I  70;LEU I  71;GLY I  65;THR I 110;VAL I 135","None","1.29A","3lxiB-5anbI:undetectable","3lxiB-5anbI:20.71"],["3Q5S_A_ACHA1289_0","MULTIDRUG-EFFLUX TRANSPORTER 1 REGULATOR","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"ASN K 342;TYR K 305;GLU K 154;ILE K 238","None","1.03A","3q5sA-5anbK:undetectable","3q5sA-5anbK:13.11"],["3QJ7_A_SPMA264_1","THYMIDYLATE SYNTHASE;THYMIDYLATE SYNTHASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"ALA K 119;LEU K 151;ASP K 149;SER K 236","None","1.01A","3qj7A-5anbK:undetectable;3qj7D-5anbK:undetectable","3qj7A-5anbK:12.20;3qj7D-5anbK:12.20"],["3T7S_B_SAMB300_0","PUTATIVE METHYLTRANSFERASE","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",5,"ARG F  38;GLY F 194;GLU F  45;ALA F 195;ASN F 196","None;  C N1226 ( 3.8A);None;  G N1225 ( 3.8A);  U N1257 ( 3.4A)","1.32A","3t7sB-5anbF:undetectable","3t7sB-5anbF:20.68"],["3T7S_D_SAMD300_0","PUTATIVE METHYLTRANSFERASE","5anb","60S RIBOSOMAL PROTEIN L10","Dictyostelium discoideum",5,"ARG F  38;GLY F 194;GLU F  45;ALA F 195;ASN F 196","None;  C N1226 ( 3.8A);None;  G N1225 ( 3.8A);  U N1257 ( 3.4A)","1.33A","3t7sD-5anbF:undetectable","3t7sD-5anbF:20.68"],["3ZQ8_D_DVAD8_0","VAL-GRAMICIDIN A","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"TRP K 848;VAL K 820;TRP K 801","None","0.88A","3zq8C-5anbK:undetectable;3zq8D-5anbK:undetectable","3zq8C-5anbK:1.54;3zq8D-5anbK:1.54"],["4AGA_A_ACTA1131_0","LYSOZYME C","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",3,"ASN I 156;ASP I 112;ASN I  21","None","0.77A","4agaA-5anbI:undetectable","4agaA-5anbI:21.05"],["4C9K_B_CAMB424_0","CYTOCHROME P450","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"LEU I  70;LEU I  71;GLY I  65;THR I 110;VAL I 135","None","1.35A","4c9kB-5anbI:undetectable","4c9kB-5anbI:20.71"],["4DC3_A_ADNA401_2","ADENOSINE KINASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"LEU K 766;ILE K 792;GLY K 832;PHE K 826","None","1.10A","4dc3A-5anbK:undetectable","4dc3A-5anbK:16.16"],["4K50_B_ACTB701_0","RNA (33-MER);RNA POLYMERASE 3D-POL","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"HIS K 353;GLY K 244;ILE K 351","None","0.60A","4k50A-5anbK:undetectable","4k50A-5anbK:17.77"],["4K50_J_ACTJ701_0","RNA (33-MER);RNA POLYMERASE 3D-POL","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"HIS K 353;GLY K 244;ILE K 351","None","0.63A","4k50I-5anbK:undetectable","4k50I-5anbK:17.77"],["4OBW_C_SAMC601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"TYR K 862;GLY K 866;ASP K 864;ILE K 823;SER K 846","None","1.28A","4obwC-5anbK:undetectable","4obwC-5anbK:13.53"],["4R21_B_STRB601_1","CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"VAL I  92;GLY I  65;ALA I  64;ILE I  97;VAL I  94","None","1.09A","4r21B-5anbI:undetectable","4r21B-5anbI:21.26"],["4X1Y_B_LOCB502_1","TUBULIN BETA CHAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"LEU K 131;LEU K 143;THR K 235;VAL K 123;ILE K 145","None","1.13A","4x1yB-5anbK:undetectable","4x1yB-5anbK:16.49"],["4X3M_B_ADNB301_1","RNA 2'-O RIBOSE METHYLTRANSFERASE","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"LEU I  81;ILE I  97;SER I  63;LEU I  71;VAL I  94","None","1.26A","4x3mB-5anbI:undetectable","4x3mB-5anbI:25.09"],["4XQE_A_AG2A505_1","HOMOSPERMIDINE SYNTHASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"ALA K 859;ASN K 845;GLU K 947;SER K 948;THR K 849","None","1.32A","4xqeA-5anbK:1.4","4xqeA-5anbK:18.52"],["4XQE_B_AG2B504_1","HOMOSPERMIDINE SYNTHASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"ALA K 859;ASN K 845;GLU K 947;SER K 948;THR K 849","None","1.32A","4xqeB-5anbK:1.8","4xqeB-5anbK:18.52"],["4XRG_B_AG2B502_1","HOMOSPERMIDINE SYNTHASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"ALA K 859;ASN K 845;GLU K 947;SER K 948;THR K 849","None","1.31A","4xrgB-5anbK:1.2","4xrgB-5anbK:18.52"],["4YIA_B_IMNB401_2","THYROXINE-BINDING GLOBULIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"LEU K 878;ARG K 970;ARG K1095","None","0.85A","4yiaB-5anbK:undetectable","4yiaB-5anbK:2.94"],["4ZE2_A_1YNA602_2","LANOSTEROL 14-ALPHA DEMETHYLASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"ALA K1037;HIS K1056;PRO K1029;PHE K1054","None","1.36A","4ze2A-5anbK:undetectable","4ze2A-5anbK:19.45"],["5DB5_A_CYSA503_0","CYSTEINE DESULFURASE","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6;ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Dictyostelium discoideum;Homo sapiens",4,"ALA I 183;LYS K 493;HIS I 162;THR I 165","None","1.32A","5db5A-5anbI:undetectable;5db5B-5anbI:undetectable","5db5A-5anbI:19.61;5db5B-5anbI:19.61"],["5DV4_A_NMYA601_2","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 6-LIKE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"GLU K 802;TRP K 801;ASN K 818","None","1.06A","5dv4A-5anbK:undetectable","5dv4A-5anbK:16.95"],["5ESG_A_1YNA701_2","LANOSTEROL 14-ALPHA DEMETHYLASE","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"LEU K 667;TYR K1090;PRO K 616;ILE K 617","None","1.27A","5esgA-5anbK:undetectable","5esgA-5anbK:19.36"],["5J6H_A_NCAA402_0","H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, Q10 ALPHA CHAIN","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"PRO K 691;ARG K 693;GLU K 885","None","0.85A","5j6hA-5anbK:undetectable","5j6hA-5anbK:14.02"],["5JKW_A_TESA601_1","AROMATASE","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"ILE I  97;ASP I 131;VAL I 137;VAL I 117;LEU I 133","None","1.32A","5jkwA-5anbI:undetectable","5jkwA-5anbI:17.53"],["5KR0_A_478A101_2","PROTEASE E35D-APV;PROTEASE E35D-APV","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",5,"LEU K 583;GLY K 586;VAL K 414;ILE K 522;VAL K 511","None","1.05A","5kr0B-5anbK:undetectable","5kr0B-5anbK:6.91"],["5LF3_H_BO2H306_1","PROTEASOME SUBUNIT BETA TYPE-7;PROTEASOME SUBUNIT BETA TYPE-3","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"GLU I 219;CYH I 197;ALA I 159;GLY I 158;THR I 155","None","1.12A","5lf3H-5anbI:undetectable;5lf3I-5anbI:undetectable","5lf3H-5anbI:21.14;5lf3I-5anbI:22.08"],["5LF7_H_6V8H305_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"GLU I 219;CYH I 197;ALA I 159;GLY I 158;THR I 155","None","1.07A","5lf7H-5anbI:undetectable;5lf7I-5anbI:undetectable","5lf7H-5anbI:21.14;5lf7I-5anbI:22.08"],["5LF7_V_6V8V303_0","PROTEASOME SUBUNIT BETA TYPE-3;PROTEASOME SUBUNIT BETA TYPE-7","5anb","EUKARYOTIC TRANSLATION INITIATION FACTOR 6","Dictyostelium discoideum",5,"GLU I 219;CYH I 197;ALA I 159;GLY I 158;THR I 155","None","1.09A","5lf7V-5anbI:undetectable;5lf7W-5anbI:undetectable","5lf7V-5anbI:21.14;5lf7W-5anbI:22.08"],["6C06_D_FI8D1404_1","DNA-DIRECTED RNA POLYMERASE SUBUNIT BETA'","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"ARG K 250;LYS K 260;ARG K 192","None","1.08A","6c06D-5anbK:undetectable","6c06D-5anbK:undetectable"],["6CDU_B_EY4B500_0","CHIMERIC ALPHA1GABAA RECEPTOR","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",4,"VAL K 577;PRO K 366;ALA K 516;THR K 407","None","0.93A","6cduB-5anbK:undetectable;6cduC-5anbK:undetectable","6cduB-5anbK:15.68;6cduC-5anbK:15.68"],["6G1P_B_ACTB403_0","ADP-RIBOSYLHYDROLASE LIKE 2","5anb","ELONGATION FACTOR TU GTP-BINDING DOMAIN-CONTAINING PROTEIN 1","Homo sapiens",3,"PHE K1065;ARG K1088;GLN K 978","None","0.86A","6g1pB-5anbK:undetectable","6g1pB-5anbK:17.27"]]